Prostate cancer detection and prevention — including use of PSA testing — topic of free CTRC public lecture

SAN ANTONIO (September 10, 2012) – Men and their loved ones who have questions about use of PSA testing in the diagnosis of prostate cancer can hear the latest information at the Cancer Therapy & Research Center’s free public lecture Thursday night.

Ian M. Thompson Jr., M.D., director of the CTRC and leader of numerous prostate cancer studies, will talk about recommendations in PSA testing, prostate cancer treatment and prevention.

The lecture, which is open to the public and has a question-and-answer session, will be Thursday, Sept. 13, from 6 to 7:30 p.m. on the fourth floor of the CTRC’s Grossman Building, 7979 Wurzbach Rd., San Antonio. For more information call 210-450-1152. It will be streamed live online at The lecture is also sponsored by H-E-B and the Institute for the Integration of Medicine and Science at the UT Health Science Center San Antonio.

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit

Share This Article!